Powerful Clinical Performance

Resolute Integrity DES makes the complex simple by demonstrating powerful clinical performance in real-world patients and provides confidence in addressing the needs of your increasingly complex daily practice.1

Drug Delivery for Resolute Integrity Is Identical to Resolute DES

  • Identical stent dimensions
  • Identical drug dose
  • Identical drug elution

Drug Delivery for Resolute Integrity Is Identical to Resolute DES

 

RESOLUTE All Comers Study Design

  • International multicentre DES clinical trial
  • 1:1 randomisation of Resolute vs. Xience V DES
  • 2300 all-comers patients reflecting real-world complexity

Compelling Results in Real-World Patients

Compelling Results in Real-World Patients

 

TLF= cardiac death, target vessel MI, clinically indicated TLR. Noninferiority p-value calculated based on a prespecified noninferiority margin of 3.5%. p-Values are based on Fisher’s Exact Test. p-Values for outcome differences are unadjusted for multiple comparisons. RESOLUTE All Comers was not specifically designed or powered to individually compare MACE and TVF.
1Serruys PW et al. NEJM 2010.

Resolute Integrity DES now has expanded indications for diabetes mellitus, multivessel disease, long lesions and small vessels.

 

Clinical Data Overview

RESOLUTE All Comers
24 Month Results Summary

 
 

Email Page

Send a link to this page by email along with your comments.
Please enter the information below.

  1. (required)
  2. (required)
  3. (required)